Best practice in precision medicine for prostate cancer
21 Oct 2025
Best practice in precision medicine for prostate cancer
ESMO 2025: Latest in EGFR mutant NSCLC
Low-dose pembrolizumab plus neoadjuvant chemo option for TNBC in resource-constrained settings
WCLC 2025: Latest in EGFR positive NSCLC
Latest advances in chronic lymphocytic leukaemia
Transforming cancer care in India: The Access Cancer Care Initiative
The hidden biology of addiction and cancer
Breast cancer survivorship
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Managing cardiotoxicities for RCC treatment – Cardiologist’s perspective
Key insights from lung cancer research at ASCO 2025
Understanding Ghana's FDA and pharmacovigilance regulations